95260 ⎘
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE
#4802Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
#4803STAT3/5 ACTIVATION INHIBITOR
#4804Heterocyclic amides as rock inhibitors
#4805Modulators of ATP-binding cassette transporters
#4806Biarylamide inhibitors of leukotriene production
#48072-acylaminopropoanol-type glucosylceramide synthase inhibitors
#4808Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
#4809Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor, a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal DNA methylation
#4810AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME
#4811Imidazole derivative
#4812Secondary 8-hydroxyquinoline-7-carboxamide derivatives
#4813AMIDE COMPOUNDS USEFUL IN THERAPY
#4814Pyridine derivatives as agonists of the CB2 receptor
#4815Compounds for inhibiting cell proliferation in EGFR-driven cancers
#4816Compounds for the Treatment of Hepatitis C
#4817Compounds comprising a spiro-ring
#4818Four-ring compound having a plurality of CFO bonding groups, liquid crystal composition and liquid crystal display device
#4819Substituted 2-imidazolidones and analogs
#4820N-benzylindole modulators of PPARG
#4821Piperazine compound having a PGDS inhibitory effect
#4822Modulators of ATP-Binding Cassette transporters
#4823Thiolactams and uses thereof
#4824Compounds
#4825Cyclic benzimidazole derivatives useful as anti-diabetic agents
#4826Cysteine protease inhibitors
#4827Neprilysin inhibitors
#4828Synthetic intermediate of oxazole compound and method for producing the same
#4829TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#4830Pyrone-indole derivatives and process for their preparation
#4831Phenyl and benzodioxinyl substituted indazoles derivatives
#4832Pyrazolines for the Modulation of PKM2
#4833Quaternary opioid carboxamides
#4834INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS
#4835THIOLACTAMS AND USES THEREOF
#4836Method of using PI3K and MEK modulators
#48374-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
#4838Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
#4839Beta-2-adrenoreceptor agonists
#4840Ethers, secondary amines and derivatives thereof as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto
#48415-amino-4-hydroxypentoyl amides
#48423-arylamino pyridine derivatives
#4843FREDERICAMYCIN DERIVATIVES
#4844Compounds useful in the synthesis of halichondrin B analogs
#4845Sulfonic acid derivative compound and novel naphthalic acid derivative compound
#4846Compounds as lysophosphatidic acid receptor antagonists
#4847Benzyl amines, a process for their production and their use as anti-inflammatory agents
#4848Potassium channel modulators
#4849Fused heterocyclic compounds as ion channel modulators
#4850Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
#4851SUBSTITUTED BENZAZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE
#4852INVERTEBRATE ACETYLCHOLINESTERASE INHIBITORS
#4853Use of rylene derivatives as photosensitizers in solar cells
#4854Cysteine protease inhibitors
#4855S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase
#4856CO-CRYSTAL OF 4-FURAN-2(5H)-ONE WITH BENZOIC ACID AND USE THEREOF AS PESTICIDE
#4857Spiroindoline modulators of muscarinic receptors
#4858Di-substituted pyridine derivatives as anticancers
#4859Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
#4860SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS
#4861Pyridine and pyrazine derivative for the treatment of CF
#4862Quinolinyloxyphenylsulfonamides
#4863BENZAMIDE COMPOUND
#4864PRODRUGS OF COMPOUNDS THAT INHIBIT TRPV1 RECEPTOR
#4865CO-CRYSTAL OF 4-FURAN-2(5H)-ONE WITH OXALIC ACID AND USE THEREOF AS PESTICIDE
#4866IRE-1α inhibitors
#4867Adamantyl diamide derivatives and uses of same
#4868Pyridyl derivatives as CFTR modulators
#4869(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors
#4870Heterocyclic compound
#4871FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS
#4872Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
#4873Ion channel modulators and methods of use
#4874Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
#4875Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
#4876PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE
#4877Heterocyclic modulators of lipid synthesis
#4878Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
#4879Aryl- or heteroaryl-substituted benzene compounds
#4880Use of physiological cooling active ingredients, and agents containing such active ingredients
#4881AMINOPYRIDINE COMPOUND
#4882Seven-membered ring compound and pharmaceutical use therefor
#4883Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof
#4884Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
#4885Substituted phenylureas and phenylamides as vanilloid receptor ligands
#4886Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
#4887Substituted isoindoline-1,3-dione derivatives
#4888Positive allosteric modulators of nicotinic acetylcholine receptor
#4889Glucokinase activators
#4890Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
#4891Quinoline amide M1 receptor positive allosteric modulators
#4892Chemical Compounds 572
#4893CO-CRYSTAL OF 4-FURAN-2(5H)-ONE WITH SALICYLIC ACID AND USE THEREOF AS PESTICIDE
#4894Opioid receptor ligands and methods of using and making same
#4895TRPV3 modulators
#4896AROMATIC COMPOUND
#4897NON-POLAR AND POLAR LEAVING GROUPS
#4898Compositions useful as inhibitors of voltage-gated sodium channels
#4899Use of substituted quinazoline compounds in treating age-related macular degeneration
#4900NOVEL UNSATURATED TETRACYCLIC TETRAHYDROFURAN DERIVATIVES
#4901Compound
#4902Nuclear Hormone Receptor Modulators
#4903AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1
#4904Labelling of fusion proteins with synthetic probes
#4905Modified drugs for use in liposomal nanoparticles
#49061,2-disubstituted heterocyclic compounds
#4907Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
#4908BENZOFURAN DERIVATIVES
#4909BENZOFURAN DERIVATIVES
#4910Fluoro-pyridinone derivatives useful as antibacterial agents
#4911Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease
#4912Quinazolines as potassium ion channel inhibitors
#49132-aminoindole compounds and methods for the treatment of malaria
#4914Modulators of ATP-Binding Cassette Transporters
#4915SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR MEDICAL USE
#4916Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
#4917Quaternary ammonium compounds useful as muscarinic receptor antagonists
#4918Aryl carboxamide derivatives as TTX-S blockers
#49193-amino-pyridines as GPBAR1 agonists
#4920Primary amine diazeniumdiolate heterocyclic derivatives
#4921Amines or amino alcohols as GLYT1 inhibitors
#4922Bicyclic compound, production and use thereof
#4923Organic compounds and their uses
#4924Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#4925INDAZOLE ANALOG
#4926Hydroxyl compounds and compositions for cholesterol management and related uses
#4927Piperidine renin inhibitors
#4928Compounds for inflammation and immune-related uses
#4929Androgen receptor modulating compounds
#4930Pyrimidine derivatives used as PI-3 kinase inhibitors
#4931Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
#4932Anti-tumor effect potentiator
#4933Topoisomerase binding probe and method of use
#4934Pesticides
#4935PREPARATION OF 11C METHYL IODIDE
#4936Asymmetric ureas and medical uses thereof
#49372-phenylethylamino derivatives as calcium and/or sodium channel modulators
#4938Quinazoline compounds
#4939Quinolinones and quinoxalinones as antibacterial composition
#4940N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses
#4941Urotensin II receptor antagonists
#4942Aminoindane compounds and use thereof in treating pain
#4943Novel Ethanediamone Hepcidine Antagonists
#4944Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#49453H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
#4946Compounds, pharmaceutical compositions and uses thereof
#4947Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
#4948Acetamide derivatives as glucokinase activators, their process and medicinal applications
#4949Neprilysin inhibitors
#4950Compositions and methods for inhibition of the JAK pathway
#49513,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
#4952Compounds, compositions and methods
#4953TOFA analogs useful in treating dermatological disorders or conditions
#4954Pyrrolidine derivatives as NK2 receptor antagonists
#4955Ion channel modulators and methods of use
#4956Inhibitors of IAP
#4957Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
#4958COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF
#4959Triazole compounds that modulate HSP90 activity
#4960Spirocyclic compounds as modulators of chemokine receptor activity
#4961USE OF PRODRUGS TO AVOID GI MEDIATED ADVERSE EVENTS
#4962Pesticidal compositions and processes related thereto
#4963Compounds for the treatment of hepatitis C
#4964Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#4965Quinazoline derivatives as angiogenesis inhibitors
#4966EPOXYCARBOXAMIDE COMPOUND, AZIDE COMPOUND, AND AMINO ALCOHOL COMPOUND, AND PROCESS FOR PREPARING a-KETO AMIDE COMPOUND USING THEM
#4967Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
#4968Sulfoximines as kinase inhibitors
#4969NEW COMPOUNDS
#4970Histone deacetylase inhibitors based simultaneously on trisubstituted 1-pyrroles and aromatic and heteroaromatic spacers
#4971Modulators of muscarinic receptors
#4972Wnt pathway antagonists
#4973THERAPEUTIC AGENT FOR CEREBRAL INFARCTION
#4974Fluorescent molecule and method for detecting target nucleic acid
#4975Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
#4976SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS
#4977TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#4978Arylalkyl esters of 4-amino-6-(substituted phenyl)-picolinates and 6-amino-2-(substituted phenyl)-pyrimidinecarboxylates and their use as selective herbicides for crops
#4979Pesticidal compositions
#4980Detection of disease related genes
#4981Inhibitors of filovirus entry into host cells
#4982Compound amycolose derivative, method for producing the same, and use of the same
#4983Substituted nicotinamides as KCNQ2/3 modulators
#4984Glycine compound
#4985Screening method for enzyme inhibitors
#4986KAPPA OPIOID RECEPTOR LIGANDS
#4987COMPOSITIONS OF AZIMILIDE DIHYDROCHLORIDE
#4988Compounds useful as inhibitors of ATR kinase
#4989Cyanoisoquinoline compounds and methods of use thereof
#4990Piperidine and piperazine phenyl sulphonamides as modulators of ion channels
#4991Aromatic amine derivative, and organic electroluminescent element
#4992Tubulin inhibitors and methods of using the same
#4993INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE
#4994NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF
#4995Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
#4996Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors
#4997Compounds and their use as BACE inhibitors
#4998Compounds for the treatment of hepatitis C
#4999Glucagon receptor modulators
#5000CYCLOPROPANE DERIVATIVES
#5001Biaryl amide derivatives
#5002Rho kinase inhibitors
#5003INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME
#5004Heterocyclic compounds for the inhibition of PASK
#5005Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#5006Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
#5007Substituted enaminocarbonyl compounds
#5008Sulfur derivatives as chemokine receptor modulators
#5009Chromone derivatives, a process for their preparation and their therapeutic applications
#5010Isoquinolin-1 (2H)-one derivatives as PARP-1 inhibitors
#50111,2-bis-sulfonamide derivatives as chemokine receptor modulators
#5012VLA-4 INHIBITORY DRUG
#5013Heteroaryl Compounds as Kinase Inhibitors
#5014Pyrimidine sulphonamide derivatives as chemokine receptor modulators
#5015Phosphorous derivatives as chemokine receptor modulators
#5016Neprilysin inhibitors
#5017NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF
#50181,4-Dihydropyridine Derivatives and Their Uses
#5019MULTIFUNCTIONAL LINKERS AND METHODS FOR THE USE THEREOF
#5020Ethylene diamine modulators of fatty acid hydrolase
#5021Platelet ADP receptor inhibitors
#5022Herbicidal pyrimidone derivatives
#5023Aromatic amine derivatives and organic electroluminescent elements using same
#5024Substituted hydrazide compounds and use thereof
#5025Acid-labile trigger units
#5026Compounds as bradykinin B1 antagonists
#5027Viral polymerase inhibitors
#5028Pyrrolidine compounds which modulate the CB2 receptor
#5029Benzamides and nicotinamides as Syk modulators
#5030Compounds as respiratory stimulants for treatment of breathing control disorders or diseases
#5031METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR
#5032Method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
#50334-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
#5034Method of hydrolyzing an enzymatic substrate
#5035Quinolone derivative or pharmaceutically acceptable salt thereof
#5036Quinolines
#5037DUAL-ACTION INHBITORS AND METHODS OF USING SAME
#5038Covalent inhibition of bacterial quorum sensing
#5039Synthetic multimerizing agents
#5040Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
#5041Metalloenzyme inhibitor compounds
#5042Inhibitors of protein kinases
#5043Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound
#5044N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
#5045Compositions and Methods for Treatment of Cardiovascular Disease
#5046Compounds as c-Met kinase inhibitors
#5047No-carrier-added nucleophilic [F-18] fluorination of aromatic compounds
#5048Quinazoline derivatives having tyrosine kinase inhibitory activity
#50491H-benzimidazole-5-carboxamides as anti-inflammatory agents
#5050Biphenyl compounds useful as muscarinic receptor antagonists
#5051NAMPT INHIBITORS
#5052DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, THEIR SYNTHESIS AND THERAPEUTIC USES
#5053Apaf-1 inhibitor compounds
#5054Biphenyl compounds useful as muscarinic receptor antagonists
#5055NAMPT and rock inhibitors
#5056Calcium sensing receptor modulating compounds and pharmaceutical use thereof
#5057Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
#5058Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
#5059Heteroaromatic pyrazinoylguanidine sodium channel blockers
#5060N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#5061NOVEL COMPOUNDS AS INHIBITORS OF RENIN
#50623H-imidazo [4, 5-B] pyridine-6-carboxamides as anti-inflammatory agents
#5063Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing the same
#5064N-BENZYL-4-METHYLENEAMINO-3-HYDROXY-2-PYRIDONES
#5065TETRAZOLE DERIVATIVES
#5066COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME
#5067Substituted arylamine compounds and methods of treatment
#5068METHOD OF CONTROLLING UNDESIRED VEGETATION
#5069Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the organic light emitting diode
#50705, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
#5071-GlcNAc transferase inhibitors and uses thereof
#5072Nicotinamides as JAK kinase modulators
#5073NEW PIPERAZINE COMPOUND AND USE THEREOF AS A HCV POLYMERASE INHIBITOR
#5074Amino-1,3,5-triazines N-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators
#5075Process for preparing [1-[1-α, 2-α, 3-β(1*,2*) 5-β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3-1,2,3-triazolo [4,5-] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediates
#5076Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
#50777-phenoxychroman carboxylic acid derivatives
#5078HISTONE DEACETYLASE INHIBITORS
#5079VIRAL POLYMERASE INHIBITORS
#5080Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
#5081Organic light-emitting device
#5082NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#5083TOLUIDINE SULFONAMIDES AND THEIR USE
#5084Compounds for activating TGF-beta signaling
#5085Substituted hydroxamic acids and uses thereof
#5086-pyridin-3-yl or -pyrazin-2-yl carboxamides
#5087PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#5088Compositions and methods for the treatment of disease associated with TRP-P8 expression
#5089Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
#5090SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS
#5091Carboxylic acid derivatives, their preparation and use
#5092Chroman derivatives
#5093AZOLE DERIVATIVES AND FUSED BICYCLIC AZOLE DERIVATIVES AS THERAPEUTIC AGENTS
#5094Compounds for enzyme inhibition
#5095AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
#5096Bioreactive agents
#5097STERICALLY HINDERED AMINE STABILIZERS
#5098Tetracyclic compound
#5099Inhibitors of hepatitis C virus replication
#5100Nicotinamide compounds useful as kinase modulators